focus -WSS

focus

author：explore 2025-09-11 10:30:15 - browse：182

Boxes of Wegovy — pharma coverage from STAT — Carsten Snejbjerg/Bloomberg

LONDON — The investment arm of Novo Nordisk’s parent foundation is buying drug manufacturer Catalent in a $16.5 billion deal, an acquisition that will give Novo additional sites as it builds up production of its booming obesity and diabetes drugs.

Under the deal, Novo Holdings is purchasing Catalent, a major contract development and manufacturing company with more than 50 sites globally. In turn, Novo Nordisk is buying three of Catalent’s fill-finish sites from the investment group for $11 billion. Novo Holdings manages the assets of the Novo Nordisk Foundation, which has a controlling stake in the pharmaceutical company.

Catalent has been involved in the production of Novo’s obesity treatment Wegovy. With the agreement, Novo will pick up sites that focus on filling drugs in Italy, Brussels, and Bloomington, Ind. All have already been doing work for Novo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Weighted lottery helped low

WSS

Congress extends some pandemic preparedness programs

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

Stop Congress from blocking public access to science

Crinetics acromegaly drug succeeds in late

How to protect patients from sexual assault

European officials brace for rough respiratory virus season

knowledge

focus

explore

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Listen: Biogen's potential pivot, & Illumina's next chapter

Medicare proposal to cover medical devices draws a mixed reaction

Weighted lottery helped low

BioMarin wins approval for gene therapy to treat hemophilia A

How generative AI is inspiring dreams of a health data revolution

In age of alternative facts, a scholarly course on calling out crap

Health insurers' Q3 question: how much care are people getting?

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Nobel honors Karikó and Weissman's enduring partnership

Wikipedia

Humana sues Biden admin over Medicare Advantage audit rule

AstraZeneca chief proposes a novel edit to the drug pricing bill

Medicaid rebukes states for mistakenly disenrolling children

What will Novo Nordisk's VC do with its influx of cash?

AstraZeneca chief proposes a novel edit to the drug pricing bill

Flu, Covid vaccination rates decline, new survey data show

knowledge

explore

focus

hotspot